Evidence map›Paper›PMID 24605340›Full record

ReviewBioMed research international2014

Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis.

A Hanyecz, K Olasz, O Tarjanyi, P Nemeth, K Mikecz, T T Glant, F Boldizsar

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Ameliorated Autoimmune Arthritis and Impaired B Cell Receptor-Mediated CaInternational journal of molecular sciences · 2020
    Article
  7. Article
  8. C-type lectins in immunity and homeostasis.Nature reviews. Immunology · 2018
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

A HanyeczDepartment of Immunology and Biotechnology, Faculty of Medicine, University of Pecs, Szigeti u. 12, Pecs 7624, Hungary.
K OlaszDepartment of Immunology and Biotechnology, Faculty of Medicine, University of Pecs, Szigeti u. 12, Pecs 7624, Hungary.
O TarjanyiDepartment of Medical Biology, University of Pecs, Szigeti u. 12, Pecs 7624, Hungary.
P NemethDepartment of Immunology and Biotechnology, Faculty of Medicine, University of Pecs, Szigeti u. 12, Pecs 7624, Hungary.
K MikeczSection of Molecular Medicine, Department of Orthopedic Surgery, Rush University Medical Center, 1735 W. Harrison Street, Chicago, IL 60612, USA.
T T GlantSection of Molecular Medicine, Department of Orthopedic Surgery, Rush University Medical Center, 1735 W. Harrison Street, Chicago, IL 60612, USA.
F BoldizsarDepartment of Immunology and Biotechnology, Faculty of Medicine, University of Pecs, Szigeti u. 12, Pecs 7624, Hungary.
University of Pecs · HURush University Medical Center · US

Funding

MAPPING OF ARTHRITIS SUSCEPTIBLE GENESP01AR045652 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI FINNEGAN, ALISON · 1999 to 2008
$9.4M
Mapping of Arthritis Susceptibility GenesR01AR059356 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI GLANT, TIBOR T. · 2010 to 2014
$2.2M
Immune Recognition of Citrullinated Cartilage PG Aggrecan in Autoimmune ArthritisR01AR064206 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI MIKECZ, KATALIN · 2013 to 2017
$1.6M
NIAMS NIH HHS AR059356NIAMS NIH HHS AR064206NIAMS NIH HHS P01 AR045652NIAMS NIH HHS R01 AR059356NIAMS NIH HHS R01 AR064206
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease and its targeting of the joints indicates the presence of a candidate autoantigen(s) in synovial joints. Patients with RA show immune responses in their peripheral blood to proteoglycan (PG) aggrecan. One of the most relevant animal models of RA appears to be proteoglycan-induced arthritis (PGIA), and CD4(+) T cells seem to play a crucial role in the initiation of the disease. In this review, the role of various T cell epitopes of aggrecan in the induction of autoreactive T cell activation and arthritis is discussed. We pay special attention to two critically important arthritogenic epitopes, 5/4E8 and P135H, found in the G1 and G3 domains of PG aggrecan, respectively, in the induction of autoimmune arthritis. Finally, results obtained with the recently developed PG-specific TCR transgenic mice system showed that altered T cell apoptosis, the balance of activation, and apoptosis of autoreactive T cells are critical factors in the development of autoimmunity.

Indexed as

AggrecansAnimalsApoptosisArthritis, ExperimentalArthritis, RheumatoidDisease Models, AnimalEpitopes, T-LymphocyteHumansLymphocyte ActivationMiceT-LymphocytesAggrecansEpitopes, T-Lymphocyte

Identifiers

PMID24605340
PMCPMC3925549
OpenAlexW2094902113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.